Richard G. Johnson Sells 15,900 Shares of Phibro Animal Health Corporation (PAHC) Stock
Phibro Animal Health Corporation (NASDAQ:PAHC) CFO Richard G. Johnson sold 15,900 shares of the stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $36.46, for a total transaction of $579,714.00. Following the completion of the transaction, the chief financial officer now owns 15,900 shares in the company, valued at approximately $579,714. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of Phibro Animal Health Corporation (PAHC) traded down 0.97% during midday trading on Friday, hitting $35.75. 267,714 shares of the stock were exchanged. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25. The company has a market cap of $1.43 billion, a price-to-earnings ratio of 22.20 and a beta of 1.36. The firm has a 50 day moving average of $37.99 and a 200-day moving average of $33.77.
Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The firm had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. During the same quarter in the prior year, the company posted $0.32 earnings per share. Phibro Animal Health Corporation’s quarterly revenue was up 3.0% on a year-over-year basis. Equities analysts expect that Phibro Animal Health Corporation will post $1.57 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a yield of 1.12%. Phibro Animal Health Corporation’s payout ratio is 24.69%.
Large investors have recently modified their holdings of the company. State of Alaska Department of Revenue lifted its position in shares of Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after acquiring an additional 1,650 shares in the last quarter. Mason Street Advisors LLC lifted its position in Phibro Animal Health Corporation by 7.1% during the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares during the period. Municipal Employees Retirement System of Michigan lifted its position in Phibro Animal Health Corporation by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after buying an additional 150 shares during the period. KBC Group NV purchased a new position in Phibro Animal Health Corporation during the second quarter worth about $166,000. Finally, Victory Capital Management Inc. lifted its position in Phibro Animal Health Corporation by 79.2% during the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares during the period. Institutional investors and hedge funds own 48.35% of the company’s stock.
PAHC has been the topic of several research reports. Piper Jaffray Companies set a $42.00 price target on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, August 25th. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Finally, Bank of America Corporation reaffirmed an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $34.00.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.